Code of Maine Rules
02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION
373 - BOARD OF LICENSURE IN MEDICINE
Chapter 12 - JOINT RULE REGARDING OFFICE BASED TREATMENT OF OPIOID USE DISORDER
Section 373-12-3 - QUALIFICATIONS
Universal Citation: 02 ME Code Rules ยง 373-12-3
Current through 2024-13, March 27, 2024
1. Clinicians who wish to provide Approved Medications for OUD in an OBOT must:
A. Hold a
current license issued by the Board;
B. Hold a current controlled substance
registration issued by the DEA;
C.
Obtain a DATA 2000 Waiver and complete buprenorphine training in accordance
with applicable State and federal laws, rules, and regulations;
D. When required by State law, physician
assistants must work in collaboration with a licensed physician when
prescribing medications for the treatment of opioid use disorder; and
E. Comply with this joint
rule.
2. Patient limits. Clinicians must be aware of and comply with limits established by the DEA regarding the number of patients that can be treated with Approved Medications in OBOT.
Disclaimer: These regulations may not be the most recent version. Maine may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
